No Data
No Data
Metagenomi Initiated at Buy by HC Wainwright & Co.
Metagenomi Initiated at Buy by HC Wainwright & Co.
Metagenomi (MGX.US) was first covered by HC Wainwright & Co., which gave it a buy rating, with a target price of $10.00.
Metagenomi (MGX.US) was first covered by HC Wainwright & Co., which gave it a buy rating, with a target price of $10.00.
HC Wainwright & Co. Initiates Coverage On Metagenomi With Buy Rating, Announces Price Target of $10
HC Wainwright & Co. analyst Mitchell Kapoor initiates coverage on Metagenomi (NASDAQ:MGX) with a Buy rating and announces Price Target of $10.
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
Thursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an income of $(0.19), smaller than the consensus estimate loss of $(3.55).The company reported sales of $167
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersEmergent BioSolutions (NYSE:EBS) stock moved upwards by 98.4% to $3.83 during Thursday's regular session. The company's market cap stands at $200.6 million. The company's, Q1 earnings came out
Metagenomi Cut to Neutral From Overweight by JP Morgan
Metagenomi Cut to Neutral From Overweight by JP Morgan
No Data